| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.06 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.055 | 0.06 |